Treatment Change and Prognosis Effect of Fiberoptic Bronchoscopic Sampling in the Intensive Care Unit
PDF
Cite
Share
Request
Original Research
P: 214-219
December 2022

Treatment Change and Prognosis Effect of Fiberoptic Bronchoscopic Sampling in the Intensive Care Unit

J Turk Soc Intens Care 2022;20(4):214-219
1. Dokuz Eylül Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, Yoğun Bakım Bilim Dalı, İzmir, Türkiye
2. Dokuz Eylül Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim dalı, Yoğun Bakım Bilim Dalı, İzmir, Türkiye
3. Medicana İnternational İzmir Hastanesi, Yoğun Bakım Ünitesi, İzmir, Türkiye
4. Dokuz Eylül Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Yoğun Bakım Bilim Dalı, İzmir, Türkiye
No information available.
No information available
Received Date: 25.05.2021
Accepted Date: 15.11.2021
Publish Date: 28.11.2022
PDF
Cite
Share
Request

ABSTRACT

Objective:

Bronchoscopy is important for the diagnosis and treatment planning of patients in the intensive care unit, especially for infectious conditions. However, increasing evidence is reported in recent guidelines showing that bronchoscopic sampling is not superior compared with endotracheal aspirate (ETA). This study aimed to evaluate the contribution of bronchoscopic sampling to antibiotic treatment and its effect on intensive care mortality.

Materials and Methods:

This retrospective observational study evaluated the data of 75 patients who were followed up under invasive mechanical ventilation using the intensive care fiberoptic bronchoscopy (FB) database.

Results:

The mean age of patients was 66.0±15.4 years, and 28 (37.32%) were female and 47 (62.7%) were male. The mean acute physiology and chronic health evaluation-II score was 23.1±6.2. Median FB timing was 7.0 (2.0-15.0) days after the intensive care unit admission. Indications for FB were infection evaluation in 44 patients, airway evaluation in 26 patients, hemoptysis-alveolar hemorrhage in 3 patients, and interstitial lung disease suspicion in 2 patients. Active immune suppression was present in 24 (32%) patients. Evaluation of ETA results revealed bacterial and fungal growth in 31 patients (41.3%). After FB sampling, 41 patients (54.6%) were found to have bacterial and fungal growth, and treatment was changed in 16 (21.3%) patients with FB sampling. However, no significant relationship was found between the change of treatment after FB and mortality in the intensive care unit (p=0.250).

Conclusion:

Our study has two important results. First, ETA and FB sampling results were found to be similar. Second, no correlation was found between treatment change after FB in the late period and mortality in intensive care. The application of FB, which is an invasive procedure, could be the right approach in selected patients.

Keywords:
Critical care, fiberoptic bronchoscopy, mortality

References

1
Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care 2014;18:208.
2
2. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J 2017;10;50:1700582. doi: 10.1183/13993003.00582-2017.
3
Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax 2013;68 Suppl 1:i1-i44.
4
Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:2619-30.
5
Ramírez P, Valencia M, Torres A. Bronchoalveolar lavage to diagnose respiratory infections. Semin Respir Crit Care Med 2007;28:525-33.
6
Sanchez JF, Ghamande SA, Midturi JK, Arroliga AC. Invasive diagnostic strategies in immunosuppressed patients with acute respiratory distress syndrome. Clin Chest Med 2014;35:697-712.
7
Mohanka MR, Mehta AC, Budev MM, Machuzak MS, Gildea TR. Impact of bedside bronchoscopy in critically ill lung transplant recipients. J Bronchology Interv Pulmonol 2014;21:199-207.
8
Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010;182:1038-46.
9
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63:e61-111.
10
Erb CT, Patel B, Orr JE, Bice T, Richards JB, Metersky ML, et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. Ann Am Thorac Soc 2016;13:2258-60.
11
Khilnani GC, Arafath TK, Hadda V, Kapil A, Sood S, Sharma SK. Comparison of bronchoscopic and non-bronchoscopic techniques for diagnosis of ventilator associated pneumonia. Indian J Crit Care Med 2011;15:16-23.
12
Cracco C, Fartoukh M, Prodanovic H, Azoulay E, Chenivesse C, Lorut C, et al. Safety of performing fiberoptic bronchoscopy in critically ill hypoxemic patients with acute respiratory failure. Intensive Care Med 2013;39:45-52.
13
Yagmurdur H, Tezcan AH, Karakurt O, Leblebici F. The efficiency of routine endotracheal aspirate cultures compared to bronchoalveolar lavage cultures in ventilator-associated pneumonia diagnosis. Niger J Clin Pract 2016;19:46-51.
14
Berton DC, Kalil AC, Teixeira PJ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev 2014;(10):CD006482.
15
Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, et al. Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur Respir J. 2019;54:1802442.
16
Al-Qadi MO, Cartin-Ceba R, Kashyap R, Kaur S, Peters SG. The Diagnostic Yield, Safety, and Impact of Flexible Bronchoscopy in Non-HIV Immunocompromised Critically Ill Patients in the Intensive Care Unit. Lung 2018;196:729-36.